Kemin Industries announced Feb. 28 a new partnership with China-based CRVAB Bio-technology Co. Ltd. that will expand Kemin's global reach in enzyme production by giving Kemin fermentation and production capabilities.

Kemin said this will allow it to directly control its enzyme production while providing customers with higher-quality solutions and greater consistency in enzyme products. Since 1980, Kemin has been a market leader in blending enzymes for animal feed.

"With this investment, we will be able to better serve more customers in the global feed enzymes markets and will become basic in enzyme production," said Dr. Chris Nelson, president and chief executive officer of Kemin Industries.

Kemin will have expanded resources for innovations in both single and blended enzymes as well as probiotic product pipelines as Kemin works on a new product portfolio to bring enzyme products to market, the announcement said. The investment will give Kemin one of the most efficient fermentation facilities in China and an accelerated ability to bring products to Kemin customers.

"We are very excited to have Kemin as a trusted partner. This will significantly improve our capability and allow us to produce products meeting the highest international quality standards," said Peijun Wu, chairman of CRVAB Bio-technology.

"As the feed and animal production industry continues to evolve, customers are searching more aggressively for innovations that add real value," Kemin Animal Nutrition & Health global group president GS Ramesh said. "This new partnership will further strengthen our capability to quickly scale up new innovations while maintaining our quality and safety standards for global regulatory requirements."

Kemin Industries is a global ingredient manufacturer with more than 500 specialty ingredients made for the human and animal health, aquaculture, pet food, nutraceutical, food technology, crop technology and textile industries.

Established in 1961, Kemin is a privately held, family-owned and -operated company with more than 2,800 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, San Marino, Singapore, South Africa and the U.S.